ADVATX 589/1319nm Dermal Workstation

25 FDA/CE CLEARED INDICATIONS

Combining the gold standard wavelength for eliminating vascular abnormalities with

the new gold standard for non-ablative resurfacing, the ADVATx allows the provider to

treat 25 FDA/CE cleared indications without the use of consumables.

One device, multiple stand-alone and combination therapies.

ADVATx uses high powered, 589nm wavelength yellow light, which is widely acknowledged as the gold standard in treating various vascular conditions, and 1319nm wavelength to stimulate collagen production and to improve skin texture and overall dermal health. Treatments with ADVATx are comfortable, with side effects usually only limited to mild swelling and redness. Significant changes in the skin can occur with each treatment.

25 FDA/CE CLEARED INDICATIONS including :

Telangiectasias

Spider veins, both facial and leg

Port wine stains

Rosacea

Melasma

Acne

Scars

Hemangiomas and angiomas

Hyper pigmentation

Venous lakes

Cherry angiomas

Skin rejuvenation

Warts

Skin rejuvenation

Reduction in the appearance of pores

Fine lines and wrinkles

Striae

Psoriasis

Poikiloderma of Civatte

Using multiple wavelengths (598 nm and 1319 nm) to treat a range of indications, the versatile solid-state ADVATx from Advalight (Copenhagen, Denmark) requires minimal maintenance and no consumables. This workhorse is sophisticated, yet easy to operate, and preset parameters enable effective treatment of most common aesthetic skin concerns including the spectrum of vascular and pigmented lesions, melasma, acne and acne scarring, wrinkles and many more, with minimum discomfort and no social downtime.

The ADVATx is cleared for use on Fitzpatrick I - V

The ability to easily change the treatment pattern also allows very selective targeting, Dr Herrmann added. “I can trace out a vessel very precisely, or target a 2 mm cherry angioma without heating surrounding skin.”

Dr Herrmann has found the combination of wavelengths applied for acne and early acne scarring to be particularly satisfying to use. “For patients with active acne, my primary concern is getting them on a combination of topicals and orals to treat the condition. But for many patients, the erythema and textural changes seen with acne and acne scarring have a significant psychological impact,” she explained. “Waiting several months for traditional prescriptions to ‘work’ is frustrating and slow. By incorporating the laser early, we can address erythema immediately and begin the scar remodelling process if scarring is already present.” “With treatments at two-week intervals, patients start noticing improvement more quickly, which also keeps them motivated to maintain compliance using their prescriptions,” Dr Herrmann continued. “And although this hasn’t been formally studied, many of my patients report decreased skin oiliness after treatments. Because of this, they feel as if their skin is improving more quickly. It’s possible that the 1319 nm wavelength is partially targeting the oil gland, and we’re continuing to look into this possibility.”

Reach out if you are interested in talking more about the ADVATx treatment and how you can combine it with other modalities in your office to boost your ROI!

Sales@advalight.com